{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:38:18Z","timestamp":1790210298736,"version":"4.1.0"},"reference-count":199,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis is a destructive small vessel vasculitis affecting multiple organs. Renal involvement often leads to end-stage renal disease and increases mortality. Prompt diagnosis and initiation of adequate immunosuppressive therapy are critical for the best patient and kidney outcomes. However, considerable heterogeneity in symptoms and severity across the patients frequently hinder the diagnosis and management. The objective of this review is to emphasize the heterogeneity of the ANCA-associated vasculitis, facilitate the recognition and give guidance to the therapeutical possibilities. We present epidemiologic and risk factors, pathogenesis, and provide comprehensive clinical features of the disease. This article also focuses on the currently available therapeutic options and emerging cellular and molecular targets for the management of systemic and especially renal disease. We conducted extensive literature research published on PubMed and Google Scholar. We systematically reviewed, analyzed, and assembled databases, covering a broad spectrum of aspects of the disease. We compared and summarized the recommendations of two recent guidelines on ANCA-associated vasculitis. The incidence of ANCA-associated vasculitis, hence glomerulonephritis shows a steady increase. Familiarity with the presenting symptoms and laboratory abnormalities are necessary for rapid diagnosis. Early initiation of treatment is the key aspect for favorable patient and renal outcomes. A better understanding of the pathogenesis constantly leads to more targeted and therefore more efficient and less toxic treatment.<\/jats:p>","DOI":"10.3389\/fmed.2022.884188","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T05:36:31Z","timestamp":1654234591000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Diagnostic and Therapeutic Approach in ANCA-Associated Glomerulonephritis: A Review on Management Strategies"],"prefix":"10.3389","volume":"9","author":[{"given":"Ad\u00e9l","family":"Moln\u00e1r","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Studinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00f3ra","family":"Led\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1136\/annrheumdis-2016-210942","article-title":"Mortality in ANCA-associated vasculitis: ameta-analysis of observational studies","volume":"76","author":"Tan","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.autrev.2012.08.006","article-title":"Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis","volume":"12","author":"Sinico","year":"2013","journal-title":"Autoimmun Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S0272-6386(03)00025-8","article-title":"Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study","volume":"41","author":"Booth","year":"2003","journal-title":"Am J Kidney Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1093\/ndt\/gfy250","article-title":"Incidence, prevalence, mortality and chronic renal damage of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in a 20-year population-based cohort","volume":"34","author":"Berti","year":"2019","journal-title":"Nephrol Dial Transplant."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa089","article-title":"An update on the epidemiology of ANCA-associated vasculitis","author":"Mohammad","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s11739-020-02431-y","article-title":"Healthcare and economic burden of ANCA-associated vasculitis in Italy: an integrated analysis from clinical and administrative databases","volume":"16","author":"Quartuccio","year":"2021","journal-title":"Intern Emerg Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.rdc.2010.04.002","article-title":"Epidemiology of ANCA-associated vasculitis","volume":"36","author":"Ntatsaki","year":"2010","journal-title":"Rheum Dis Clin North Am."},{"key":"B8","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s11926-005-0036-5","article-title":"Epidemiology of systemic vasculitis","volume":"7","author":"Lane","year":"2005","journal-title":"Curr Rheumatol Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1093\/rheumatology\/kei259","article-title":"The epidemiology of Wegener's granulomatosis and microscopic polyangiitis in a Southern Hemisphere region","volume":"45","author":"Gibson","year":"2006","journal-title":"Rheumatology (Oxford)."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw384","article-title":"Clinical trials in antineutrophil cytoplasmic antibody-associated vasculitis: what we have learnt so far, and what we still have to learn","author":"Cornec","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"B11","doi-asserted-by":"publisher","first-page":"A293","DOI":"10.1016\/j.autrev.2009.10.008","article-title":"The environment, geoepidemiology and ANCA-associated vasculitides","volume":"9","author":"Chen","year":"2010","journal-title":"Autoimmun Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1002\/art.40313","article-title":"The epidemiology of antineutrophil cytoplasmic autoantibody-associated vasculitis in Olmsted County, Minnesota: a twenty-year US population-based study","volume":"69","author":"Berti","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/ndt\/gfy106","article-title":"Proteinase-3 and myeloperoxidase serotype in relation to demographic factors and geographic distribution in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis","volume":"34","author":"Weiner","year":"2019","journal-title":"Nephrol Dial Transplant."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.2215\/CJN.01461005","article-title":"Incidence of ANCA-associated primary renal vasculitis in the Miyazaki Prefecture: the first population-based, retrospective, epidemiologic survey in Japan","volume":"1","author":"Fujimoto","year":"2006","journal-title":"Clin J Am Soc Nephrol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3899\/jrheum.090688","article-title":"Incidence of Wegener's granulomatosis in children","volume":"37","author":"Grisaru","year":"2010","journal-title":"J Rheumatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1590\/2175-8239-jbn-2018-0062","article-title":"Anca-associated crescentic glomerulonephritis in a child with isolated renal involvement","volume":"41","author":"Celakil","year":"2019","journal-title":"J Bras Nefrol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1136\/ard.60.2.170","article-title":"Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe","volume":"60","author":"Watts","year":"2001","journal-title":"Ann Rheum Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/art.11115","article-title":"The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions","volume":"49","author":"Gonzalez-Gay","year":"2003","journal-title":"Arthritis Rheum."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.2215\/CJN.02500317","article-title":"ANCA Glomerulonephritis and Vasculitis","volume":"12","author":"Jennette","year":"2017","journal-title":"Clin J Am Soc Nephrol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"24479","DOI":"10.1038\/s41598-021-04274-9","article-title":"Kidney biopsy-based epidemiologic analysis shows growing biopsy rate among the elderly","volume":"11","author":"Molnar","year":"2021","journal-title":"Sci Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3389\/fimmu.2014.00577","article-title":"Genetic susceptibility to ANCA-associated vasculitis: state of the art","volume":"5","author":"Bonatti","year":"2014","journal-title":"Front Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3390\/jcm8020266","article-title":"Genetic Variants in antineutrophil cytoplasmic antibody-associated vasculitis: a bayesian approach and systematic review","volume":"8","author":"Lee","year":"2019","journal-title":"J Clin Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1056\/NEJMoa1108735","article-title":"Genetically Distinct Subsets within ANCA-Associated Vasculitis","volume":"367","author":"Lyons","year":"2012","journal-title":"N Engl J Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"624848","DOI":"10.3389\/fimmu.2021.624848","article-title":"Antineutrophil cytoplasmic antibody-associated vasculitis update: genetic pathogenesis","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"102660","DOI":"10.1016\/j.autrev.2020.102660","article-title":"Environmental risk factors associated with ANCA associated vasculitis: a systematic mapping review","volume":"19","author":"Scott","year":"2020","journal-title":"Autoimmun Rev."},{"key":"B26","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1053\/j.ajkd.2021.06.016","article-title":"ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine","volume":"78","author":"Shakoor","year":"2021","journal-title":"Am J Kidney Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.kint.2021.05.017","article-title":"ANCA glomerulonephritis after the Moderna COVID-19 vaccination","volume":"100","author":"Sekar","year":"2021","journal-title":"Kidney Int."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e19616","DOI":"10.7759\/cureus.19616","article-title":"De-novo Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Following the mRNA-1273 (Moderna) Vaccine for COVID-19","volume":"13","author":"Feghali","year":"2021","journal-title":"Cureus."},{"key":"B29","doi-asserted-by":"publisher","first-page":"762006","DOI":"10.3389\/fimmu.2021.762006","article-title":"Case Report: ANCA-Associated Vasculitis Presenting With Rhabdomyolysis and Pauci-Immune Crescentic Glomerulonephritis After Pfizer-BioNTech COVID-19 mRNA Vaccination","volume":"12","author":"Hakroush","year":"2021","journal-title":"Front Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"765447","DOI":"10.3389\/fmed.2021.765447","article-title":"Case report: anti-neutrophil cytoplasmic antibody-associated vasculitis with acute renal failure and pulmonary hemorrhage may occur after COVID-19 vaccination","volume":"8","author":"Chen","year":"2021","journal-title":"Front Med (Lausanne)."},{"key":"B31","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4103\/jisp.jisp_385_15","article-title":"Neutrophil priming: Implications in periodontal disease","volume":"21","author":"Shah","year":"2017","journal-title":"J Indian Soc Periodontol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"7319","DOI":"10.3390\/ijms21197319","article-title":"Immunopathogenesis of ANCA-Associated Vasculitis","volume":"21","author":"Kronbichler","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41584-018-0145-y","article-title":"Pathogenesis and therapeutic interventions for ANCA-associated vasculitis","volume":"15","author":"Nakazawa","year":"2019","journal-title":"Nat Rev Rheumatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil extracellular traps in immunity and disease","volume":"18","author":"Papayannopoulos","year":"2018","journal-title":"Nat Rev Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3389\/fimmu.2016.00302","article-title":"New insights into neutrophil extracellular traps: mechanisms of formation and role in inflammation","volume":"7","author":"Yang","year":"2016","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.celrep.2014.06.044","article-title":"myeloperoxidase-containing complex regulates neutrophil elastase release and actin dynamics during NETosis","volume":"8","author":"Metzler","year":"2014","journal-title":"Cell Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"15880","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA traps promote thrombosis","volume":"107","author":"Fuchs","year":"2010","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B38","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ekir.2018.11.005","article-title":"Clinical Implications of Excessive neutrophil extracellular trap formation in renal autoimmune diseases","volume":"4","author":"van Dam","year":"2019","journal-title":"Kidney Int Rep."},{"key":"B39","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/ar1222","article-title":"The current status of targeting BAFF\/BLyS for autoimmune diseases","volume":"6","author":"Ramanujam","year":"2004","journal-title":"Arthritis Res Ther."},{"key":"B40","doi-asserted-by":"publisher","first-page":"102911","DOI":"10.1016\/j.autrev.2021.102911","article-title":"Monocytes and macrophages in ANCA-associated vasculitis","volume":"20","author":"Vegting","year":"2021","journal-title":"Autoimmun Rev."},{"key":"B41","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/ar3362","article-title":"T-helper cells as new players in ANCA-associated vasculitides","volume":"13","author":"Abdulahad","year":"2011","journal-title":"Arthritis Res Ther."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.3899\/jrheum.111608","article-title":"Persistent or new onset microscopic hematuria in patients with small vessel vasculitis in remission: findings on renal biopsy","volume":"39","author":"Geetha","year":"2012","journal-title":"J Rheumatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int."},{"key":"B44","doi-asserted-by":"publisher","first-page":"656","DOI":"10.7326\/0003-4819-113-9-656","article-title":"Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The glomerular disease collaborative network","volume":"113","author":"Falk","year":"1990","journal-title":"Ann Intern Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1007\/s10157-012-0736-x","article-title":"Skin involvement in ANCA-associated vasculitis","volume":"17","author":"Chen","year":"2013","journal-title":"Clin Exp Nephrol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1001\/archderm.141.7.873","article-title":"Initial cutaneous manifestations consistent with mononeuropathy multiplex in Churg-Strauss syndrome","volume":"141","author":"Kawakami","year":"2005","journal-title":"Arch Dermatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s12016-017-8616-5","article-title":"Cutaneous Manifestations of ANCA-Associated Small Vessels Vasculitis","volume":"53","author":"Marzano","year":"2017","journal-title":"Clin Rev Allergy Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/jop.12030","article-title":"Wegener's granulomatosis: a review of clinical features and an update in diagnosis and treatment","volume":"42","author":"Almouhawis","year":"2013","journal-title":"J Oral Pathol Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.amjmed.2004.02.030","article-title":"The antineutrophil cytoplasmic antibody-associated vasculitides","volume":"117","author":"Seo","year":"2004","journal-title":"Am J Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/rheumatology\/kei217","article-title":"Pulmonary manifestations of anti-neutrophil cytoplasmic antibody (ANCA)-positive vasculitis","volume":"45","author":"Thickett","year":"2006","journal-title":"Rheumatology (Oxford)."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e6024","DOI":"10.1097\/MD.0000000000006024","article-title":"Granulomatosis with polyangiitis presenting with diffuse alveolar hemorrhage requiring extracorporeal membrane oxygenation with rapid multiorgan relapse: a case report","volume":"96","author":"Vanoli","year":"2017","journal-title":"Medicine (Baltimore)."},{"key":"B52","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/00005792-199901000-00003","article-title":"Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients","volume":"78","author":"Guillevin","year":"1999","journal-title":"Medicine (Baltimore)."},{"key":"B53","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/art.37721","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort","volume":"65","author":"Comarmond","year":"2013","journal-title":"Arthritis Rheum."},{"key":"B54","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/MLG.0b013e318159889d","article-title":"Nasal polyposis in Churg-Strauss syndrome","volume":"118","author":"Bacciu","year":"2008","journal-title":"Laryngoscope."},{"key":"B55","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1080\/00016480500437435","article-title":"Ear, nose and throat manifestations of Churg-Strauss syndrome","volume":"126","author":"Bacciu","year":"2006","journal-title":"Acta Otolaryngol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1183\/09031936.00110109","article-title":"Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis","volume":"36","author":"Tzelepis","year":"2010","journal-title":"Eur Respir J."},{"key":"B57","first-page":"329","article-title":"Intestinal involvement in Wegener's granulomatosis","volume":"16","author":"Deniz","year":"2007","journal-title":"J Gastrointestin Liver Dis."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1393140","article-title":"Eosinophilic granulomatosis with polyangiitis involving the small intestine: radiographic and endoscopic findings","author":"Kawasaki","year":"2015","journal-title":"Endoscopy"},{"key":"B59","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1159\/000369129","article-title":"Eosinophilic granulomatosis with polyangiitis and diffuse gastrointestinal involvement","volume":"8","author":"Franco","year":"2014","journal-title":"Case Rep Gastroenterol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/ckj\/sfv020","article-title":"The kidneys and ANCA-associated vasculitis: from pathogenesis to diagnosis","volume":"8","author":"Rowaiye","year":"2015","journal-title":"Clin Kidney J."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.3389\/fneur.2018.01166","article-title":"Central nervous system involvement in ANCA-associated vasculitis: what neurologists need to know","volume":"9","author":"Zheng","year":"2018","journal-title":"Front Neurol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/BOR.0b013e32834115f9","article-title":"Neurological involvement in Wegener's granulomatosis","volume":"23","author":"Holle","year":"2011","journal-title":"Curr Opin Rheumatol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/s11102-017-0811-0","article-title":"Pituitary dysfunction in granulomatosis with polyangiitis","volume":"20","author":"Esposito","year":"2017","journal-title":"Pituitary."},{"key":"B64","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.rdc.2010.05.005","article-title":"Ocular manifestations of ANCA-associated vasculitis","volume":"36","author":"Kubal","year":"2010","journal-title":"Rheum Dis Clin North Am."},{"key":"B65","doi-asserted-by":"publisher","first-page":"10","DOI":"10.22336\/rjo.2021.3","article-title":"Therapy of ocular complications in ANCA+ associated vasculitis","volume":"65","author":"Sorin","year":"2021","journal-title":"Rom J Ophthalmol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"620","DOI":"10.7326\/0003-4819-142-8-200505030-00011","article-title":"Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study","volume":"142","author":"Merkel","year":"2005","journal-title":"Ann Intern Med."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez617","article-title":"Comorbidities in ANCA-associated vasculitis","author":"Kronbichler","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"B68","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.berh.2012.12.004","article-title":"Cardiovascular disease due to accelerated atherosclerosis in systemic vasculitides","volume":"27","author":"Cohen Tervaert","year":"2013","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12876-021-01730-8","article-title":"Gastrointestinal symptoms as first remarkable signs of ANCA-associated granulomatosis with polyangiitis: a case report and reviews","volume":"21","author":"Led\u00f3","year":"2021","journal-title":"BMC Gastroenterol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.chest.2021.02.049","article-title":"Pleuritis and pericarditis in antineutrophil cytoplasmic autoantibody-associated vasculitis","volume":"160","author":"Thompson","year":"2021","journal-title":"Chest."},{"key":"B71","doi-asserted-by":"publisher","first-page":"41","DOI":"10.20517\/2574-1209.2021.41","article-title":"Ear, nose, and throat in ANCA-associated vasculitis: a comprehensive review","volume":"5","author":"Padoan","year":"2021","journal-title":"Vessel Plus."},{"key":"B72","doi-asserted-by":"publisher","first-page":"104039","DOI":"10.1016\/j.lpm.2020.104039","article-title":"Lung involvement in ANCA-associated vasculitis","volume":"49","author":"Sacoto","year":"2020","journal-title":"La Presse M\u00e9dicale."},{"key":"B73","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/BOR.0000000000000344","article-title":"Systemic vasculitis and the gut","volume":"29","author":"Hatemi","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"2040622320987051","DOI":"10.1177\/2040622320987051","article-title":"Cardiac manifestations of eosinophilic granulomatosis with polyangiitis from a single-center cohort in China: clinical features and associated factors","volume":"12","author":"Liu","year":"2021","journal-title":"Ther Adv Chronic Dis."},{"key":"B75","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/art.41983","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology Classification Criteria for Microscopic Polyangiitis","volume":"74","author":"Suppiah","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1136\/annrheumdis-2021-221795","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis","volume":"81","author":"Robson","year":"2022","journal-title":"Ann Rheum Dis."},{"key":"B77","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1136\/annrheumdis-2021-221794","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis","volume":"81","author":"Grayson","year":"2022","journal-title":"Ann Rheum Dis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3389\/fimmu.2017.00439","article-title":"Neutrophil extracellular traps contain selected antigens of anti-neutrophil cytoplasmic antibodies","volume":"8","author":"Panda","year":"2017","journal-title":"Front Immunol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2324709620974874","DOI":"10.1177\/2324709620974874","article-title":"Renal limited ANCA-positive vasculitis: a rare manifestation of a rare disease","volume":"8","author":"Khan","year":"2020","journal-title":"J Investig Med High Impact Case Rep."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13317-020-00143-z","article-title":"ANCA-negative microscopic polyangiitis with diffuse alveolar hemorrhage masquerading as congestive heart failure","volume":"12","author":"Mollaeian","year":"2021","journal-title":"Autoimmunity Highlights."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1093\/ndt\/gfx248","article-title":"Vasculitis-when can biopsy be avoided?","volume":"32","author":"Jayne","year":"2017","journal-title":"Nephrol Dial Transplant."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1093\/ndt\/gfh830","article-title":"ANCA-negative pauci-immune renal vasculitis: histology and outcome","volume":"20","author":"Eisenberger","year":"2005","journal-title":"Nephrol Dial Transplant."},{"key":"B83","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1053\/gast.2000.9366","article-title":"\u201cAtypical p-ANCA\u201d in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines","volume":"119","author":"Terjung","year":"2000","journal-title":"Gastroenterology."},{"key":"B84","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1046\/j.1365-2249.1999.00905.x","article-title":"Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)?","volume":"116","author":"Roozendaal","year":"1999","journal-title":"Clin Exp Immunol."},{"key":"B85","first-page":"373","volume":"87","author":"Ghosh","year":"2014","journal-title":"Yale J Biol Med."},{"key":"B86","doi-asserted-by":"publisher","first-page":"190321","DOI":"10.1183\/20734735.0321-2019","article-title":"Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients","volume":"16","author":"Suarez-Cuartin","year":"2020","journal-title":"Breathe."},{"key":"B87","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1006\/jaut.1997.0186","article-title":"Antineutrophil cytoplasmic autoantibodies (ANCA) in children with cystic fibrosis","volume":"11","author":"Sediva","year":"1998","journal-title":"J Autoimmun."},{"key":"B88","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.3892\/ol.2016.4855","article-title":"Possible intrinsic association of anti-neutrophil cytoplasmic antibody-associated vasculitis coexisting with multiple myeloma","volume":"12","author":"Liu","year":"2016","journal-title":"Oncol Lett."},{"key":"B89","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000509099","article-title":"A case of myeloma kidney with perinuclear anti-neutrophil cytoplasmic antibody and anti-myeloperoxidase positivity: the importance of determining the true cause of renal impairment","volume":"10","author":"Roper","year":"2020","journal-title":"Case Rep Nephrol Dial."},{"key":"B90","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ejr.2020.06.002","article-title":"Antineutrophil cytoplasmic autoantibody (ANCA) positive immunoglobulin A (IgA) nephropathy: Case reports and review of literature","volume":"42","author":"Chebotareva","year":"2020","journal-title":"Egypt Rheumatol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1111\/j.1523-1755.2004.00917.x","article-title":"Clinical features and outcome of patients with both ANCA and anti-GBM antibodies","volume":"66","author":"Levy","year":"2004","journal-title":"Kidney Int."},{"key":"B92","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1093\/ndt\/gfy075","article-title":"Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis","volume":"33","author":"McAdoo","year":"2018","journal-title":"Nephrol Dial Transplant."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1046\/j.1523-1755.2003.00843.x","article-title":"Rapidly progressive crescentic glomerulonephritis","volume":"63","author":"Jennette","year":"2003","journal-title":"Kidney Int."},{"key":"B94","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/j.1440-1797.2011.01484.x","article-title":"Incidence and features of dual anti-GBM-positive and ANCA-positive patients","volume":"16","author":"J","year":"2011","journal-title":"Nephrology (Carlton)"},{"key":"B95","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/cei.13498","article-title":"The alternative complement pathway in ANCA-associated vasculitis: further evidence and a meta-analysis","volume":"202","author":"Moiseev","year":"2020","journal-title":"Clin Exp Immunol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s40620-017-0445-3","article-title":"Serum C3 complement levels in ANCA associated vasculitis at diagnosis is a predictor of patient and renal outcome","volume":"31","author":"Crnogorac","year":"2018","journal-title":"J Nephrol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.2215\/CJN.00120115","article-title":"Association of serum C3 concentration and histologic signs of thrombotic microangiopathy with outcomes among patients with ANCA-associated renal vasculitis","volume":"10","author":"Manenti","year":"2015","journal-title":"Clin J Am Soc Nephrol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s12882-017-0754-8","article-title":"Anaemia is an essential complication of ANCA-associated renal vasculitis: a single center cohort study","volume":"18","author":"Kawamura","year":"2017","journal-title":"BMC Nephrol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis","volume":"75","author":"Yates","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1681\/ASN.2010050477","article-title":"Histopathologic classification of ANCA-associated glomerulonephritis","volume":"21","author":"Berden","year":"2010","journal-title":"J Am Soc Nephrol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/ndt\/16.5.953","article-title":"Renal histopathology and clinical course in 94 patients with Wegener's granulomatosis","volume":"16","author":"Aasar\u00f8d","year":"2001","journal-title":"Nephrol Dial Transplantat."},{"key":"B102","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1053\/ajkd.2003.50142","article-title":"Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity","volume":"41","author":"Vizjak","year":"2003","journal-title":"Am J Kidney Dis."},{"key":"B103","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/08998280.2017.11929645","article-title":"Medullary angiitis and pauci-immune crescentic glomerulonephritis","volume":"30","author":"Klein","year":"2017","journal-title":"Proc (Bayl Univ Med Cent)."},{"key":"B104","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1016\/j.ekir.2021.07.002","article-title":"Renal Involvement in Eosinophilic Granulomatosis With Polyangiitis","volume":"6","author":"Doreille","year":"2021","journal-title":"Kidney Int Rep."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1093\/ndt\/gfu042","article-title":"Repeat protocol renal biopsy in ANCA-associated renal vasculitis","volume":"29","author":"Hruskova","year":"2014","journal-title":"Nephrol Dial Transplantat."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1093\/rheumatology\/keab695","article-title":"Utility of interval kidney biopsy in ANCA-associated vasculitis","volume":"61","author":"Chapman","year":"2021","journal-title":"Rheumatology"},{"key":"B107","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3109\/14397595.2013.854075","article-title":"Assessment of the Birmingham vasculitis activity score in patients with MPO-ANCA-associated vasculitis: sub-analysis from a study by the Japanese Study Group for MPO-ANCA-associated vasculitis","volume":"24","author":"Yumura","year":"2014","journal-title":"Mod Rheumatol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"i76","DOI":"10.1093\/ndt\/gfv002","article-title":"Disease assessment in systemic vasculitis","volume":"1","author":"Luqmani","year":"2015","journal-title":"Nephrol Dial Transplant."},{"key":"B109","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/art.1780400222","article-title":"Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides","volume":"40","author":"Exley","year":"1997","journal-title":"Arthritis Rheum."},{"key":"B110","first-page":"31","article-title":"Development and validation of a disease extent index for Wegener's granulomatosis","volume":"55","author":"de Groot","year":"2001","journal-title":"Clin Nephrol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/00005792-199601000-00003","article-title":"Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients","volume":"75","author":"Guillevin","year":"1996","journal-title":"Medicine (Baltimore)."},{"key":"B112","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/ard.2008.097758","article-title":"Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis","volume":"68","author":"Merkel","year":"2009","journal-title":"Ann Rheum Dis."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/art.41773","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody\u2013Associated Vasculitis","volume":"73","author":"Chung","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1056\/NEJMoa1803537","article-title":"Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis","volume":"382","author":"Walsh","year":"2020","journal-title":"N Engl J Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ekir.2017.11.004","article-title":"Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis","volume":"3","author":"Cortazar","year":"2018","journal-title":"Kidney Int Rep."},{"key":"B116","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa2023386","article-title":"Avacopan for the Treatment of ANCA-Associated Vasculitis","volume":"384","author":"Jayne","year":"2021","journal-title":"N Engl J Med."},{"key":"B117","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/00005792-197311000-00002","article-title":"Wegener's granulomatosis: studies in eighteen patients and a review of the literature","volume":"52","author":"Fauci","year":"1973","journal-title":"Medicine."},{"key":"B118","doi-asserted-by":"publisher","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial","volume":"150","author":"de Groot","year":"2009","journal-title":"Ann Intern Med."},{"key":"B119","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1681\/ASN.2014010046","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement","volume":"26","author":"Geetha","year":"2015","journal-title":"J Am Soc Nephrol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1136\/annrheumdis-2019-216863","article-title":"Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis","volume":"79","author":"Smith","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1136\/annrheumdis-2015-208073","article-title":"Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type","volume":"75","author":"Unizony","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B123","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13075-020-02215-x","article-title":"Favorable efficacy of rituximab in ANCA-associated vasculitis patients with excessive B cell differentiation","volume":"22","author":"Miyazaki","year":"2020","journal-title":"Arthritis Res Ther."},{"key":"B124","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med."},{"key":"B125","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1136\/annrheumdis-2018-214245","article-title":"Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial","volume":"78","author":"Jones","year":"2019","journal-title":"Ann Rheum Dis."},{"key":"B126","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1053\/j.ajkd.2019.04.031","article-title":"ANCA-Associated Vasculitis: Core Curriculum 2020","volume":"75","author":"Geetha","year":"2020","journal-title":"Am J Kidney Dis."},{"key":"B127","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1053\/j.ajkd.2010.10.049","article-title":"Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis","volume":"57","author":"Walsh","year":"2011","journal-title":"Am J Kidney Dis."},{"key":"B128","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1681\/ASN.2007010090","article-title":"Randomized Trial of Plasma Exchange or High-Dosage Methylprednisolone as Adjunctive Therapy for Severe Renal Vasculitis","volume":"18","author":"Jayne","year":"2007","journal-title":"J Am Soc Nephrol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"e064604","DOI":"10.1136\/bmj-2021-064604","article-title":"The effects of plasma exchange in patients with ANCA-associated vasculitis: an updated systematic review and meta-analysis","volume":"376","author":"Walsh","year":"2022","journal-title":"BMJ."},{"key":"B130","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/jca.21820","article-title":"Update to the ASFA guidelines on the use of therapeutic apheresis in ANCA-associated vasculitis","volume":"35","author":"Balogun","year":"2020","journal-title":"J Clin Apher."},{"key":"B131","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1056\/NEJMoa020286","article-title":"A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies","volume":"349","author":"Jayne","year":"2003","journal-title":"N Engl J Med."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1056\/NEJMoa1404231","article-title":"Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis","volume":"371","author":"Guillevin","year":"2014","journal-title":"N Engl J Med."},{"key":"B133","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13063-017-1857-z","article-title":"Rituximab versus azathioprine as therapy for maintenance of remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM): study protocol for a randomized controlled trial","volume":"18","author":"Gopaluni","year":"2017","journal-title":"Trials."},{"key":"B134","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1001\/jama.2010.1658","article-title":"Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial","volume":"304","author":"Hiemstra","year":"2010","journal-title":"JAMA."},{"key":"B135","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1056\/NEJMoa0802311","article-title":"Azathioprine or Methotrexate Maintenance for ANCA-Associated Vasculitis","volume":"359","author":"Pagnoux","year":"2008","journal-title":"N Engl J Med."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1002\/acr.20176","article-title":"Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis","volume":"62","author":"Walsh","year":"2010","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"B137","doi-asserted-by":"publisher","year":"2019","journal-title":"Ann Rheum Dis","DOI":"10.1136\/annrheumdis-2017-212878corr1"},{"key":"B138","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/rap\/rkab018","article-title":"Predicting relapse in anti-neutrophil cytoplasmic antibody-associated vasculitis: A Systematic review and meta-analysis","volume":"5","author":"King","year":"2021","journal-title":"Rheumatol Adv Pract"},{"key":"B139","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ekir.2019.10.005","article-title":"Relapse in Anti-Neutrophil Cytoplasm Antibody (ANCA)-Associated Vasculitis","volume":"5","author":"Salama","year":"2020","journal-title":"Kidney Int Rep."},{"key":"B140","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s12016-012-8320-4","article-title":"Antineutrophil Cytoplasmic Autoantibodies: How Are They Detected and What Is Their Use for Diagnosis, Classification and Follow-up?","volume":"43","author":"Cohen Tervaert","year":"2012","journal-title":"Clin Rev Allergy Immunol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1681\/ASN.2013111233","article-title":"ANCA as a Predictor of Relapse: Useful in Patients with Renal Involvement But Not in Patients with Nonrenal Disease","volume":"26","author":"Kemna","year":"2015","journal-title":"J Am Soc Nephrol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1002\/art.30362","article-title":"Sialylation levels of anti\u2013proteinase 3 antibodies are associated with the activity of granulomatosis with polyangiitis (Wegener's)","volume":"63","author":"Espy","year":"2011","journal-title":"Arthritis Rheumatism."},{"key":"B143","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1172\/JCI65292","article-title":"Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis","volume":"123","author":"Roth","year":"2013","journal-title":"J Clin Invest."},{"key":"B144","doi-asserted-by":"publisher","first-page":"967","DOI":"10.2215\/CJN.06250519","article-title":"Treatment of Relapses in ANCA-Associated Vasculitis","volume":"14","author":"McClure","year":"2019","journal-title":"Clin J Am Soc Nephrol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J","article-title":"An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients","volume":"43","author":"Reinhold-Keller","year":"2000","journal-title":"Arthritis Rheum"},{"key":"B146","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham Vasculitis Activity Score (version 3)","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis."},{"key":"B147","first-page":"100","article-title":"Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients","volume":"35","author":"Faurschou","year":"2008","journal-title":"J Rheumatol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1056\/NEJMra1009433","article-title":"Intravenous immune globulin in autoimmune and inflammatory diseases","volume":"367","author":"Gelfand","year":"2012","journal-title":"N Engl J Med."},{"key":"B149","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/art.39472","article-title":"Intravenous Immunoglobulin as an Immunomodulating Agent in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A French Nationwide Study of Ninety-Two Patients","volume":"68","author":"Crickx","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"5653612","DOI":"10.1155\/2018\/5653612","article-title":"Prognostic factors in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis with severe glomerular sclerosis: a national registry-based cohort study","volume":"2018","author":"Bj\u00f8rneklett","year":"2018","journal-title":"Patholog Res Int"},{"key":"B151","doi-asserted-by":"publisher","first-page":"6369814","DOI":"10.1155\/2018\/6369814","article-title":"Prognostic factors for survival and relapse in ANCA-Associated vasculitis with renal involvement: a Clinical Long-Term Follow-up Study","volume":"2018","author":"Salmela","year":"2018","journal-title":"Int J Nephrol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1136\/jcp.49.11.942","article-title":"Effect of diagnostic delay on disease severity and outcome in glomerulonephritis caused by anti-neutrophil cytoplasmic antibodies","volume":"49","author":"Lal","year":"1996","journal-title":"J Clin Pathol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.kint.2018.07.020","article-title":"Development and validation of a renal risk score in ANCA-associated glomerulonephritis","volume":"94","author":"Brix","year":"2018","journal-title":"Kidney Int."},{"key":"B154","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/ndt\/gfab250","article-title":"Kidney biopsy chronicity grading in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"16","author":"Moura","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"B155","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.3390\/jcm10122682","article-title":"Systematic scoring of tubular injury patterns reveals interplay between distinct tubular and glomerular lesions in ANCA-associated glomerulonephritis","volume":"10","author":"Hakroush","year":"2021","journal-title":"J Clin Med."},{"key":"B156","doi-asserted-by":"publisher","first-page":"621","DOI":"10.7326\/0003-4819-143-9-200511010-00005","article-title":"Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis","volume":"143","author":"Hogan","year":"2005","journal-title":"Ann Intern Med."},{"key":"B157","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1681\/ASN.V7123","article-title":"Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis","volume":"7","author":"Hogan","year":"1996","journal-title":"J Am Soc Nephrol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3109\/03009742.2012.754939","article-title":"Long-term outcome of severe alveolar haemorrhage in ANCA-associated vasculitis: a retrospective cohort study","volume":"42","author":"Hruskova","year":"2013","journal-title":"Scand J Rheumatol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/annrheumdis-2013-203927","article-title":"Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials","volume":"74","author":"Robson","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"B160","doi-asserted-by":"publisher","first-page":"4616","DOI":"10.1093\/rheumatology\/keab057","article-title":"Venous thromboembolism in ANCA-associated vasculitis: a population-based cohort study","volume":"60","author":"Liapi","year":"2021","journal-title":"Rheumatology (Oxford)."},{"key":"B161","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.berh.2012.12.003","article-title":"ANCA-associated vasculitis and malignancy: Current evidence for cause and consequence relationships","volume":"27","author":"Mahr","year":"2013","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.semcancer.2011.12.004","article-title":"Inflammation and immune surveillance in cancer","volume":"22","author":"Chow","year":"2012","journal-title":"Semin Cancer Biol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3748\/wjg.v20.i3.684","article-title":"Role of Helicobacter pylori in gastric mucosa-associated lymphoid tissue lymphomas","volume":"20","author":"Pereira","year":"2014","journal-title":"World J Gastroenterol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1172\/JCI31405","article-title":"Immune surveillance of tumors","volume":"117","author":"Swann","year":"2007","journal-title":"J Clin Invest."},{"key":"B165","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nrclinonc.2009.146","article-title":"Cyclophosphamide and cancer: golden anniversary","volume":"6","author":"Emadi","year":"2009","journal-title":"Nat Rev Clin Oncol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1136\/annrheumdis-2016-209925","article-title":"Effect of rituximab on malignancy risk in patients with ANCA-associated vasculitis","volume":"76","author":"van Daalen","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B167","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1556\/2060.2021.00006","article-title":"Incidence and clinical predictors of infections in patients treated with severe systemic ANCA-associated vasculitis","volume":"108","author":"Haris","year":"2021","journal-title":"Physiol Int."},{"key":"B168","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12882-018-0933-2","article-title":"Risk factors for infectious complications of ANCA-associated vasculitis: a cohort study","volume":"19","author":"Yang","year":"2018","journal-title":"BMC Nephrol"},{"key":"B169","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.ekir.2020.12.037","article-title":"Incidence and Temporal Trend in Risk Factors of Severe Infections in ANCA-Glomerulonephritis Patients","volume":"6","author":"Jourdain","year":"2021","journal-title":"Kidney Int Rep."},{"key":"B170","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/eci.12410","article-title":"Frequency, risk factors and prophylaxis of infection in ANCA-associated vasculitis","volume":"45","author":"Kronbichler","year":"2015","journal-title":"Eur J Clin Invest."},{"key":"B171","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/ajh.25642","article-title":"Preventing infectious complications when treating non-malignant immune-mediated hematologic disorders","volume":"94","author":"Malpica","year":"2019","journal-title":"Am J Hematol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1093\/rheumatology\/kez390","article-title":"High rate of indeterminate results of the QuantiFERON-TB Gold in-tube test, third generation, in patients with systemic vasculitis","volume":"59","author":"Rousset","year":"2019","journal-title":"Rheumatology."},{"key":"B173","doi-asserted-by":"publisher","first-page":"e2077","DOI":"10.1002\/rmv.2077","article-title":"Progressive multifocal leukoencephalopathy and anti-CD20 monoclonal antibodies: What do we know after 20 years of rituximab","volume":"29","author":"Focosi","year":"2019","journal-title":"Rev Med Virol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3899\/jrheum.180784","article-title":"Vaccination guidelines for patients with immune-mediated disorders taking immunosuppressive therapies: executive summary","volume":"46","author":"Papp","year":"2019","journal-title":"J Rheumatol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/ki.2009.218","article-title":"The clinical course of ANCA small-vessel vasculitis on chronic dialysis","volume":"76","author":"Lionaki","year":"2009","journal-title":"Kidney Int."},{"key":"B176","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1053\/j.ajkd.2015.03.025","article-title":"Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry","volume":"66","author":"Hruskova","year":"2015","journal-title":"Am J Kidney Dis."},{"key":"B177","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1097\/TP.0b013e31821ab9aa","article-title":"Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis: a multicenter experience","volume":"91","author":"Geetha","year":"2011","journal-title":"Transplantation."},{"key":"B178","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1097\/TP.0000000000000910","article-title":"The Dutch Transplantation in Vasculitis (DUTRAVAS) Study: Outcome of Renal Transplantation in Antineutrophil Cytoplasmic Antibody-associated Glomerulonephritis","volume":"100","author":"G\u00f6\u00e7eroglu","year":"2016","journal-title":"Transplantation."},{"key":"B179","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s41927-020-00137-4","article-title":"Serum 20S proteasome levels are associated with disease activity in MPO-ANCA-associated microscopic polyangiitis","volume":"4","author":"Maruyama","year":"2020","journal-title":"BMC Rheumatol."},{"key":"B180","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1681\/ASN.2010010034","article-title":"Myeloperoxidase-specific plasma cell depletion by bortezomib protects from anti-neutrophil cytoplasmic autoantibodies-induced glomerulonephritis","volume":"22","author":"Bontscho","year":"2011","journal-title":"J Am Soc Nephrol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1136\/annrheumdis-2015-207947","article-title":"Bortezomib in refractory ANCA-associated vasculitis: a new option?","volume":"75","author":"Novikov","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B182","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1136\/annrheumdis-2014-206016","article-title":"The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus","volume":"74","author":"Alexander","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"B183","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3390\/jcm10071446","article-title":"ANCA-associated vasculitis: an update","volume":"10","author":"Almaani","year":"2021","journal-title":"J Clin Med"},{"key":"B184","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1136\/annrheumdis-2016-eular.5464","article-title":"AB0531 The role of hydroxychloroquine in ANCA positive and negative vasculitis","volume":"75","author":"Casian","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B185","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2147\/DDDT.S67264","article-title":"Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF\/APRIL targeting agents","volume":"9","author":"Lenert","year":"2015","journal-title":"Drug Des Devel Ther."},{"key":"B186","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/art.40802","article-title":"Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Controlled Study","volume":"71","author":"Jayne","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"B187","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1742-7843.2009.00375.x","article-title":"Abatacept, a Novel CD80\/86\u2013CD28 T Cell Co-stimulation Modulator, in the Treatment of Rheumatoid Arthritis","volume":"104","author":"Korhonen","year":"2009","journal-title":"Basic Clin Pharmacol Toxicol."},{"key":"B188","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1136\/annrheumdis-2013-204164","article-title":"An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's)","volume":"73","author":"Langford","year":"2014","journal-title":"Ann Rheum Dis."},{"key":"B189","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ekir.2019.11.021","article-title":"Treatment of Aggressive Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Eculizumab","volume":"5","author":"Huizenga","year":"2020","journal-title":"Kidney Int Rep."},{"key":"B190","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.41407","article-title":"New Therapeutic Targets in Antineutrophil Cytoplasm Antibody\u2013Associated Vasculitis","volume":"73","author":"Prendecki","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"B191","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1177\/1352458520908040","article-title":"New cases of vasculitis after alemtuzumab","volume":"26","author":"Azevedo","year":"2020","journal-title":"Mult Scler."},{"key":"B192","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1177\/1352458519895449","article-title":"ANCA-associated life-threatening systemic vasculitis after alemtuzumab treatment for multiple sclerosis","volume":"26","author":"Horisberger","year":"2020","journal-title":"Mult Scler."},{"key":"B193","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1007\/s10067-017-3752-0","article-title":"Current clinical evidence of tocilizumab for the treatment of ANCA-associated vasculitis: a prospective case series for microscopic polyangiitis in a combination with corticosteroids and literature review","volume":"36","author":"Sakai","year":"2017","journal-title":"Clin Rheumatol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3389\/fimmu.2016.00227","article-title":"Peptidylarginine Deiminase Inhibitor Suppresses Neutrophil Extracellular Trap Formation and MPO-ANCA Production","volume":"7","author":"Kusunoki","year":"2016","journal-title":"Front Immunol"},{"key":"B195","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1016\/j.ekir.2019.05.033","article-title":"SAT-012 Peptidyl Arginase Deiminase 4 inhibition attenuates inflammation in murine experimental myeloperoxidase cytoplasmic antibody associated glomerulonephritis","volume":"4","author":"O'Sullivan","year":"2019","journal-title":"Kidney Int Rep."},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/ve38dj","article-title":"Efficacy of leflunomide in the treatment of vasculitis","author":"Mustapha","year":"2021","journal-title":"Clin Exp Rheumatol."},{"key":"B197","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/rheumatology\/kez063.026","article-title":"302. Alemtuzumab for relapsing and refractory primary systemic vasculitis - a trial of efficacy and safety (aleviate): a randomized open-label phase II clinical trial","volume":"58","author":"Gopaluni","year":"2019","journal-title":"Rheumatology"},{"key":"B198","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.jaip.2020.09.054","article-title":"Benralizumab as a Steroid-Sparing Treatment Option in Eosinophilic Granulomatosis with Polyangiitis","volume":"9","author":"Guntur","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B199","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.anai.2021.01.035","article-title":"Efficacy and safety of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis","volume":"126","author":"Manka","year":"2021","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.884188\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T05:36:39Z","timestamp":1654234599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.884188\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,3]]},"references-count":199,"alternative-id":["10.3389\/fmed.2022.884188"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.884188","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,3]]},"article-number":"884188"}}